Propensity Score-based Comparison of Long-term Outcomes With 3-Dimensional Conformal Radiotherapy vs Intensity-Modulated Radiotherapy for Esophageal Cancer

ACS. Esophageal Cancer. Available at: www.cancer.org/Cancer/EsophagusCancer/DetailedGuide/esophagus-cancer-key-statistics. 2012 Cancer Statistics. Accessed February 6, 2012. Fenkell, 2008, Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus, Radiother Oncol, 89, 287, 10.1016/j.radonc.2008.08.008 Chandra, 2005, Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer, Radiother Oncol, 77, 247, 10.1016/j.radonc.2005.10.017 Nutting, 2001, A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy, Radiother Oncol, 61, 157, 10.1016/S0167-8140(01)00438-8 Wu, 2004, Target dose conformity in 3-dimensional conformal radiotherapy and intensity modulated radiotherapy, Radiother Oncol, 71, 201, 10.1016/j.radonc.2004.03.004 Wu, 2004, Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer, Br J Radiol, 77, 568, 10.1259/bjr/19972578 Robins, 2000, Marginal structural models and causal inference in epidemiology, Epidemiology, 11, 550, 10.1097/00001648-200009000-00011 Sugihara, 2009, Survival analysis using inverse probability of treatment weighted methods based on the generalized propensity score, Pharm Stat, 9, 21, 10.1002/pst.365 Therneau, 1990, Martingale-based residuals for survival models, Biometrika, 77, 147, 10.1093/biomet/77.1.147 Grambsch, 1994, Proportional hazards tests and diagnostics based on weighted residuals, Biometrika, 81, 515, 10.1093/biomet/81.3.515 D'Agostino, 1998, Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group, Stat Med, 17, 2265, 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B Boivin, 1992, Coronary artery disease mortality in patients treated for Hodgkin's disease, Cancer, 69, 1241, 10.1002/cncr.2820690528 Cosset, 1991, Pericarditis and myocardial infarctions after Hodgkin's disease therapy, Int J Radiat Oncol Biol Phys, 21, 447, 10.1016/0360-3016(91)90794-5 Joensuu, 1989, Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease, Chest, 95, 388, 10.1378/chest.95.2.388 Minsky, 2002, INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy, J Clin Oncol, 20, 1167, 10.1200/JCO.20.5.1167 Ishikura, 2003, Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus, J Clin Oncol, 21, 2697, 10.1200/JCO.2003.03.055 Morota, 2009, Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma, Int J Radiat Oncol Biol Phys, 75, 122, 10.1016/j.ijrobp.2008.10.075 La, 2010, Multimodality treatment with intensity modulated radiation therapy for esophageal cancer, Dis Esophagus, 23, 300, 10.1111/j.1442-2050.2009.01004.x Takahashi, 2010, The role of intensity modulated radiotherapy (IMRT) for locally advanced esophageal cancer, Jap J Clin Radiol, 55, 1114 Lin, 2011, Intensity-modulated or 3-D conformal radiotherapy combined with chemotherapy with docetaxel and cisplatin for locally advanced esophageal carcinoma, Nan Fang Yi Ke Da Xue Xue Bao, 31, 1264